The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSabien Tech. Regulatory News (SNT)

Share Price Information for Sabien Tech. (SNT)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12.50
Bid: 12.00
Ask: 13.00
Change: 0.00 (0.00%)
Spread: 1.00 (8.333%)
Open: 12.50
High: 12.50
Low: 12.50
Prev. Close: 12.50
SNT Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

17 Dec 2018 14:49

RNS Number : 7226K
Sabien Technology Group PLC
17 December 2018
 

For immediate release

17 December 2018

 

Sabien Technology Group plc("Sabien" or the "Company")

Holding(s) in Company

 

The Board of Sabien announces that the Company has received the following TR-1 notification which is set out below.

 

A copy of this announcement is available on the Company's website at http://www.sabien-tech.co.uk

 

For further information please contact:

 

Sabien Technology Group plc

Alan O'Brien

 

 

Tel: +44(0)20 7993 3700

Beaumont Cornish Limited

Michael Cornish / Roland Cornish

www.beaumontcornish.com

(Nominated Advisor)

 

 

Tel: +44(0)20 7628 3396

Peterhouse Capital Limited

(Broker)

Martin Lampshire and Fungai Ndoro

Tel: +44 (0) 20 7469 0930

 

This announcement is inside information for the purposes of Article 7 of Regulation 596/20014. The person who arranged for the release of this announcement on behalf of the Company was Alan O'Brien, Chief Executive Officer.

 

 

TR-1: Standard form for notification of major holdings

 

NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible)i

1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attachedii:

Sabien Technology Group Plc

1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)

Non-UK issuer

2. Reason for the notification (please mark the appropriate box or boxes with an "X")

An acquisition or disposal of voting rights

X

An acquisition or disposal of financial instruments

An event changing the breakdown of voting rights

Other (please specify)iii:

3. Details of person subject to the notification obligationiv

Name

Dewscope Limited

City and country of registered office (if applicable)

Bolton, Lancashire

4. Full name of shareholder(s) (if different from 3.)v

Name

City and country of registered office (if applicable)

5. Date on which the threshold was crossed or reachedvi:

14th December 2018

6. Date on which issuer notified (DD/MM/YYYY):

17th December 2018

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8. A)

% of voting rights through financial instruments(total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights of issuervii

Resulting situation on the date on which threshold was crossed or reached

12.7%

590,254,867

Position of previous notification (if

applicable)

 

8. Notified details of the resulting situation on the date on which the threshold was crossed or reachedviii

A: Voting rights attached to shares

Class/type ofshares

ISIN code (if possible)

Number of voting rightsix

% of voting rights

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

Direct

(Art 9 of Directive 2004/109/EC) (DTR5.1)

Indirect

(Art 10 of Directive 2004/109/EC) (DTR5.2.1)

75,000,000

SUBTOTAL 8. A

75,000,000

12.7%

 

 

B 1: Financial Instruments according to Art. 13(1)(a) of Directive 2004/109/EC (DTR5.3.1.1 (a))

Type of financial instrument

Expirationdatex

Exercise/Conversion Periodxi

Number of voting rights that may be acquired if the instrument is

exercised/converted.

% of voting rights

SUBTOTAL 8. B 1

 

 

B 2: Financial Instruments with similar economic effect according to Art. 13(1)(b) of Directive 2004/109/EC (DTR5.3.1.1 (b))

Type of financial instrument

Expirationdatex

Exercise/Conversion Period xi

Physical or cash

settlementxii

Number of voting rights

% of voting rights

SUBTOTAL 8.B.2

 

 

 

 

9. Information in relation to the person subject to the notification obligation (please mark the

applicable box with an "X")

Person subject to the notification obligation is not controlled by any natural person or legal entity and does not control any other undertaking(s) holding directly or indirectly an interest in the (underlying) issuerxiii

Full chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held starting with the ultimate controlling natural person or legal entityxiv (please add additional rows as necessary)

Namexv

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

10. In case of proxy voting, please identify:

Name of the proxy holder

The number and % of voting rights held

The date until which the voting rights will be held

11. Additional informationxvi

 

Place of completion

London

Date of completion

17th December 2018

 

 

ENDS

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
HOLGGGMCPUPRGCM
Date   Source Headline
12th Oct 20227:00 amRNSHolding(s) in Company
5th Oct 20223:33 pmRNSHolding(s) in Company
23rd Sep 20222:49 pmRNSHolding(s) in Company
20th Sep 20224:16 pmRNSHolding(s) in Company
16th Sep 20227:00 amRNSRevised Date for Summit for S'th Korean Delegation
31st Aug 20225:00 pmRNSTotal Voting Rights
25th Aug 20223:30 pmRNSAdmission to trading of new Ordinary Shares
22nd Aug 20226:24 pmRNSResult of General Meeting
19th Aug 20227:00 amRNSSales Channel Partnership
16th Aug 20227:00 amRNSHolding(s) in Company
16th Aug 20227:00 amRNSExtension of Sales Agency Agreement
5th Aug 20225:15 pmRNSNotice of GM & Holdings in the Company
4th Aug 20227:00 amRNSOversubscribed Broker Option to raise £100,000
3rd Aug 20227:00 amRNSPlacing to raise £500,000 & Broker Option
8th Jul 202212:45 pmRNSHolding(s) in Company
7th Jul 20227:00 amRNSTrading Update
7th Jun 20227:00 amRNSHolding(s) in Company
13th May 20227:00 amRNSWelsh Freeport
5th May 20227:00 amRNSUpdate on b.grn
11th Apr 20221:00 pmRNSCorporate Update - Contract Win
4th Apr 20225:00 pmRNSProject COFFEE - Replacement
4th Apr 20222:30 pmRNSProject COFFEE
31st Mar 20224:02 pmRNSHalf-year Report
31st Mar 20227:00 amRNSHolding(s) in Company
25th Mar 20227:00 amRNSContract Win
3rd Feb 20222:03 pmRNSHolding(s) in Company
2nd Feb 20227:00 amRNSMOU signed with Irish Renewable Fuels Ltd.
1st Feb 20222:43 pmRNSLicence agreement with Proton Technologies Canada
18th Jan 20227:00 amRNSChanges to Warrant Terms
14th Jan 20224:25 pmRNSHolding(s) in Company
31st Dec 202112:00 pmRNSTotal Voting Rights
22nd Dec 20217:00 amRNSAgreement for Establishment of SPV
26th Nov 20217:00 amRNSWarrant Exercise
11th Nov 20217:00 amRNSLicence agreement with Proton Technologies
4th Nov 20217:00 amRNSRole of Carbon Credits, Blockchain & Carbon Market
1st Nov 20217:00 amRNSCOP26: Sabien hosts Green Economics Debate
29th Oct 20215:00 pmRNSTotal Voting Rights
14th Oct 20213:00 pmRNSResult of AGM
14th Oct 202110:00 amRNSSabien Presentation at FTE Mykonos
14th Oct 20218:00 amRNSIssue of Equity
14th Oct 20217:30 amRNSAGM Statement
14th Oct 20217:00 amRNSSubscription and possible Co-operation Agreement
21st Sep 20217:00 amRNSHolding(s) in Company
16th Sep 20211:02 pmRNSAeristech: Investor Update
16th Sep 202111:30 amRNSHolding(s) in Company
15th Sep 20217:00 amRNSSales Agency Agreement
14th Sep 20216:00 pmRNSPosting of Annual Report & Notice of AGM
31st Aug 20217:12 amRNSFinal Results for the year to 30 June 2021
31st Aug 20217:00 amRNSFinal Results for the Year to 30 June 2021
10th Aug 202112:12 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.